Antiangiogenic Activity of the Selective Cyclooxygenase 2 Inhibitor Rofecoxib in Human Colorectal Cancer Liver Metastases

Gut - United Kingdom
doi 10.1136/gut.2005.090571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ